The 2023/2024 Global NASH ASPIRE from Pfizer supports basic science, pre-clinical research, and clinical research that advances medical knowledge and clinical knowledge of nonalcoholic steatohepatitis (NASH) pathophysiology, co-morbidities associated with the disease and innovative approaches to diagnose, manage and treat NASH as well as support academic research development of promising emerging and established scientists around the globe. Applications are open to researchers at research institutions worldwide. The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
Applicants may apply for up to 140,000 USD in funding support (including up to 28% of overheads) for 1-2 years.
Applications close on January 4, 2024.
January 4, 2024